Perrigo Company plc
90.60-0.48 (-0.53%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close91.08
Bid90.45 x 200
Ask90.50 x 200
52wk Range84.85 - 198.42
Day's Range90.10 - 91.34
Avg Vol (3m)2,397,566
As of 11:19 AM EDT. NYSE Real Time Price. Market open.
  • Reuters2 days ago

    Teva, Allergan win U.S. antitrust approval for generics deal

    Teva Pharmaceutical Industries Ltd won U.S. antitrust approval to purchase Allergan Plc's generics business, after agreeing to divest 79 generic drugs to rival firms, the Federal Trade Commission said on Wednesday. The $40.5 billion deal, which was announced in July 2015, solidifies Teva's position as the world's No. 1 maker of generics while freeing Allergan to focus on branded drugs. Teva will sell rights and assets related to the 79 pharmaceutical products to 11 rival firms, marking the largest ever drug divestiture order in an FTC pharmaceutical merger case, the commission said in a statement.

  • TheStreet.com7 days ago

    It's Time to Sell These 5 Big Stocks This Summer

    Owning these stocks could be toxic to your portfolio.